Viewing Study NCT01839357


Ignite Creation Date: 2025-12-24 @ 6:43 PM
Ignite Modification Date: 2026-02-02 @ 4:59 AM
Study NCT ID: NCT01839357
Status: COMPLETED
Last Update Posted: 2016-07-25
First Post: 2013-04-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Exploring the Efficacy of Once Daily Oral Rivaroxaban for Treatment of Thrombus in Left Atrial/Left Atrial Appendage in Subjects With Nonvalvular Atrial Fibrillation or Atrial Flutter
Sponsor: Bayer
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Atrial Fibrillation View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Rivaroxaban View
None Oral anticoagulant View
None Nonvalvular atrial fibrillation View
None Left atrial thrombus View
None Transesophageal echocardiography View
None Thrombus resolution View
None Stroke View
None Thromboembolism View